Pharma Delays European Drug Launches Over US Pricing Policy
Drug manufacturers are delaying European launches as most-favored-nation pricing threatens to compress US revenues, reshaping global launch strategies in 2026.
Trump administration
3 articles tagged "Trump administration"
Trump Pushes Drug Pricing Legislation in 2026
The White House is circulating draft drug pricing legislation to major pharma companies, escalating Trump's push to reshape U.S. medication pricing policy.
Trump Drug Prices: Public Opinion vs. Biotech Pushback
A KFF poll reveals partisan divides on Trump drug pricing confidence, while biotech firms publicly challenge the most-favored nation pricing proposal.
By James Liu